-
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialWang TY, Kaltenbach LA, Cannon CP et al. -
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)H Bulluck, V Paradies, DJ Hausenloy et al.
-
Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary SyndromeG Pemmasani, I Elgendy, MA Mamas et al.
-
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)J-P Collet, H Thiele, E Barbato et al.
-
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)M Banach, PE Penson, ACS EuroPath Central & South European Countries Project et al.
-
Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesSchüpke S, Neumann FJ, ISAR-REACT 5 Trial Investigators.
-
Pharmacotherapy in the Management of Anxiety and Pain During Acute Coronary Syndromes and the Risk of Developing Symptoms of Posttraumatic Stress DisorderR von Känel, J-P Schmid, RE Meister-Langraf et al.
-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
